Redcare Pharmacy NV (ETR:RDC)
Germany flag Germany · Delayed Price · Currency is EUR
70.25
+1.45 (2.11%)
Oct 2, 2026, 5:36 PM CET

Redcare Pharmacy NV Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €87.60. The average 1-year stock price forecast is 24.70% higher than the current stock price, while the lowest is €55.00 (-21.71%) and the highest is €116.00 (+65.12%).

Price Target: €87.60 (+24.70%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price€55.00€87.60€89.50€116.00
Change-21.71%+24.70%+27.40%+65.12%

Analyst Ratings

The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy444555
Buy222222
Hold333333
Sell000000
Strong Sell000000
Total999101010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
€110.00 → €114.00
BuyMaintains€110.00 → €114.00+62.28%Sep 30, 2026
Deutsche Bank
Deutsche Bank
Buy
Maintains
€103.00 → €104.00
BuyMaintains€103.00 → €104.00+48.04%Sep 29, 2026
Jefferies
Jefferies
Buy
Maintains
€97.00
BuyMaintains€97.00+38.08%Sep 28, 2026
Barclays
Barclays
Buy
Reiterates
€85.00
BuyReiterates€85.00+21.00%Aug 12, 2026
UBS
UBS
Hold
Maintains
€60.00 → €74.00
HoldMaintains€60.00 → €74.00+5.34%Jul 31, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
3.44B
from 2.94B
Increased by 16.86%
Revenue Next Year
3.84B
from 3.44B
Increased by 11.72%
EPS This Year
-0.36
from -1.40
EPS Next Year
1.24
from -0.36
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.06B1.20B1.80B2.37B2.94B3.44B
Revenue Growth
9.53%13.58%49.36%31.79%24.06%16.86%
Gross Profit
266.80M331.79M440.38M545.80M663.10M755.88M
Gross Margin
25.16%27.55%24.48%23.02%22.55%21.99%
Operating Income
-32.25M-47.23M-3.79M-39.00M-20.10M26.54M
Net Income
-74.19M-77.65M-12.04M-45.50M-37.70M-9.29M
EPS
-----1.40-0.36
Free Cash Flow
-----87.60M-43.10M
No. Analysts
-----9
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High3.5B
Avg3.4B
Low3.4B

Revenue Growth

Revenue Growth202620272028
High
17.7%
Avg
16.9%
Low
16.0%

EPS Forecast

EPS202620272028
High-0.01
Avg-0.36
Low-0.67

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-